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Brain function and behavior undergo significant plasticity and refinement, particularly
during specific critical and sensitive periods. In autistic and intellectual disability (ID)
neurodevelopmental disorders (NDDs) and their corresponding genetic mouse models,
impairments in many neuronal and behavioral phenotypes are temporally regulated
and in some cases, transient. However, the links between neurobiological mechanisms
governing typically normal brain and behavioral development (referred to also as
“neurotypical” development) and timing of NDD impairments are not fully investigated.
This perspective highlights temporal patterns of synaptic and neuronal impairment,
with a restricted focus on autism and ID types of NDDs. Given the varying known
genetic and environmental causes for NDDs, this perspective proposes two strategies
for investigation: (1) a focus on neurobiological mechanisms underlying known critical
periods in the (typically) normal-developing brain; (2) investigation of spatio-temporal
expression profiles of genes implicated in monogenic syndromes throughout affected
brain regions. This approach may help explain why many NDDs with differing genetic
causes can result in overlapping phenotypes at similar developmental stages and better
predict vulnerable periods within these disorders, with implications for both therapeutic
rescue and ultimately, prevention.
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RATIONALE AND BACKGROUND
Cognitive disorders, including intellectual disability (ID) and
autism spectrum disorders (ASD) are genetically and phenotyp-
ically highly heterogeneous. To date, more than 450 candidate
genes are associated with ID and many hundreds with ASD—
numbers predicted to rise with the routine usage of high through-
put sequencing technology (Mitchell, 2011; van Bokhoven, 2011;
State and Sestan, 2012). Despite the heterogeneity of genes under-
lying both syndromic and non-syndromic forms of ID and ASD,
they are often characterized by early onset of symptoms, overlap-
ping developmental delays and prominent regression of acquired
behaviors in ASD during early childhood (Geschwind and Levitt,
2007). However, the underlying mechanisms and early temporal
dysregulation in neuronal signaling pathways that trigger neu-
rodevelopmental disorder (NDD) onset and regulate symptoms
are not fully understood.
Many known candidate genes for both ID and ASD are
expressed synaptically, regulate synapse function and morphol-
ogy or are themselves regulated by synaptic activity (Ramakers,
2000; Zoghbi and Bear, 2012). For known monogenic NDD
syndromes, genetic mouse models such as the Fragile X men-
tal retardation 1 knockout (Fmr1-KO) mouse for Fragile X
syndrome (FXS; Bakker et al., 1994) or tuberous sclerosis
protein 1/2 (TSC 1/2) models for tuberous sclerosis (Meikle
et al., 2007; Ehninger et al., 2008) have enabled the func-
tional study of these genes in the intact brain. For many
such mouse models, the target gene is permanently disrupted
early on in development, either globally or in a cell-type spe-
cific manner. Nevertheless, recent data reveal developmentally
regulated and transient synaptic phenotypes in NDD models
despite a permanent alteration in genotype (Meredith et al.,
2012).
Here, we propose that key developmental aspects of NDD
symptoms can be better understood by focusing on the interac-
tions between synaptic NDD gene pathways and the underlying
known critical periods in the neurotypical brain. Further, we
propose that clustering NDD gene groups on their neuro-spatio-
temporal expression profiles, rather than biological functions
alone, may reveal novel NDD genes and explain the develop-
mental regulation of specific symptoms. Combining knowledge
of key gene networks dysregulated in NDDs and their role during
critical periods may elucidate causal mechanisms for symptom
onset and further our understanding of critical periods in neu-
rotypical brain development. The ideas presented are formulated
as three testable hypotheses for validation in known genetic NDD
syndromes (Box 1).
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BOX 1 | Hypothesis
Hypothesis 1
Dysregulation of synaptic pathways occurs at the subcortical level
in NDDs at ‘presymptomatic’ stages.
Hypothesis 2
Dysruption of critical periods in subcortical regions such as brain-
stem precedes and consequently disrupts critical periods in thala-
mus and then cortex.
Hypothesis 3
No differences in synaptic networks or critical periods in NDDs
occur prior to the neurotypical pre- or postnatal expression of the
NDD gene in that brain region.
DEVELOPMENTAL DELAYS AND POSTNATAL ONSET IN NDDs
Although ASDs and several forms of ID are heterogeneous, symp-
toms often emerge during early development. Initial symptoms
such as hypotonia and developmental delay of motor activities,
impaired social interactions, repetitive behaviors and epileptic
seizures can manifest early in life (Zoghbi and Bear, 2012). Hypo-
tonia during early neonatal periods is correlated with delayed
motor skill development in infancy and characteristic for many
monogenic disorders including FXS, Angelman syndrome and
syndromic Oligophrenin-1 mutation ID (OPHN1; Kau et al.,
2000; Bergmann et al., 2003; Clayton-Smith and Laan, 2003;
Williams et al., 2006). Additionally, there is high comorbidity of
epilepsy in ID and autism and often, seizure activity is devel-
opmentally regulated (Gillberg and Billstedt, 2000; Amiet et al.,
2008; Ramamoorthi and Lin, 2011). For OPHN1 ID, absence
and myoclonic jerks often develop into seizures with increasing
frequency in the first 12 months (Bergmann et al., 2003). In Rett
Syndrome, developmentally regulated seizures also occur along
with regression of behaviors after 6–18 months of neurotypi-
cal progress (Steffenburg et al., 2001; Weaving et al., 2005). In
many such disorders, the earlier the onset of first symptoms,
the more severe the locomotor dysfunction and impairments
in language acquisition (Gratchev et al., 2001). Impairments in
speech and social interactions are commonly reported to be
delayed in syndromes such as FXS and Angelman, where they
may be characterized as core symptoms or as part of an ASD
comorbid with ID (Gillberg and Billstedt, 2000; Amiet et al.,
2008; Ramamoorthi and Lin, 2011). Altogether, the overlap-
ping symptoms, their temporally restricted onset and an overall
developmental delay suggest a common NDD etiology in brain
development.
The impact of developmental delays is not just confined to
symptom onset but could extend beyond the presentation period
to disrupt subsequent developmental stages. This concept of
“sleeper effects” is illustrated for permanent visual impairments
emerging later on in life due to a lack of early sensory experience
(Maurer et al., 2007). Early hypotonia and impaired motor skills,
or aberrant sensory modulation and social avoidance are paired
examples where earlier developmental impairments can have
lasting consequences upon later behavior, despite the fact that the
initial impairment was transient or lessened with age (Baranek
et al., 2006; Ben-Sasson et al., 2009). Although these reports
were not longitudinal, the correlations suggest that impairments
of sensory or motor functions affect the acquisition of com-
plex behaviors such as speech, language and social interaction.
However, while the prevalence of sensory impairments is signif-
icantly greater in those with ID than in the general population
(Carvill, 2001) it is important to note that not all pre- or early
postnatal sensory impairments such as congenital blindness or
deafness are associated with later diagnosis of ID or autistic
syndromes. The strong association with sensory impairments
may, in part, arise from infections or perinatal events that cause
extensive neurological damage but for genetic conditions such as
Usher syndrome, specific visual and auditory impairments can
occur without cognitive or social disabilities. Regardless of the
genetic and environmental heterogeneity in underlying NDDs,
impaired development is characteristic for both syndromic and
non-syndromic NDDs. Here, within the category of NDDs we
focus on genetically identified IDs and ASDs as these disor-
ders are widely studied in humans and investigated in animal
models. Further, we speculate that the syndromic and nonsyn-
dromic disorders converge on similar developmentally regulated
mechanisms.
CRITICAL PERIODS AND NORMAL BRAIN DEVELOPMENT
Critical periods are developmental time-windows during which
external stimuli have a heightened influence on the proper devel-
opment of an organism. While the early stages of development
are largely based on hard-wired genetic and molecular cues
(Chilton, 2006;Marin et al., 2010), at later stages neuronal activity
becomes an important factor contributing to circuit development
in the brain (Lendvai et al., 2000; Spitzer, 2006). This activity
can be intrinsically generated (Golshani et al., 2009; Rochefort
et al., 2009) or induced by sensory stimulation (Siegel et al.,
2012). Although neuronal circuits remain malleable by external
stimuli throughout life, most circuits are especially sensitive to
external input during restricted time-windows, or critical periods
(Knudsen, 2004; Hensch, 2005). Consequently, disruptions of
external input have amuch greater effect during the critical period
than at other times and these effects can be irreversible. In the
primary visual cortex (V1) of the cat, prolonged closure of one
eyelid in kittens, shifts V1 neuron responsiveness toward the open
eye (Wiesel and Hubel, 1963). This effect is largely absent in
adult cats. Since then, this shift in ocular dominance in juvenile
mammals has become the most widely studied instance of a
critical period. Subsequently, critical periods have been found
in many cortical regions and sensory modalities, such as the
somatosensory (Fox, 2002) and auditory systems (Barkat et al.,
2011; Yang et al., 2012).
Development is typically a set of processes influencing both
behavioral and biological characteristics which occur sequentially
(Michel and Tyler, 2005). It is interesting to note that there
seems to be a sequential hierarchical structure to the order in
which different critical periods occur. In somatosensory cortex,
restricted critical periods for thalamocortical and then cortico-
cortical synapse connectivity and maturation occur in a regulated
layer-specific sequence (Fox, 2002; Feldmeyer et al., 2013). In the
visual cortex, layer IV receives subcortical input, which is subse-
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quently processed in both superficial and deep layers. The critical
period for ocular dominance in these cortical layers lasts longer
than that of inputs to layer IV (Daw et al., 1992). This may explain
why there seems to be a lack of clearly defined critical periods for
higher order functions involving sensory cortical networks spread
across different layers. In the visual condition amblyopia (lazy
eye), treatment is most effective in young children, but it can also
still be treated in adults (Polat et al., 2004). This phenomenon
whereby sensory plasticity underlying acquired behaviors can
occur in the adult nervous system, albeit at a less effective level,
also applies to the auditory system. For example, in congenitally
deaf children, cochlear implants are most effective when treat-
ment starts at an early age. The earlier the implantation, the more
likely these children are to develop spoken language (Nicholas
and Geers, 2007). Children who receive cochlear implants after
the age of seven do not develop normal cortical responses to
auditory stimuli (Sharma et al., 2009). However, there is no
clear cut-off when cochlear implantation ceases to be useful,
as implantation after this age does improve hearing (Harrison
et al., 2005). Similarly, although second-language acquisition is
most effective when started before the age of 4, adults retain the
ability to learn new languages, albeit less fluently (Werker and
Tees, 2005). Furthermore, musicians who start musical training
before age 7 on average ultimately perform better than those
who start training at a later age (Penhune, 2011), but learning
to play music is still possible during adulthood. Thus, develop-
mental time-frames for plasticity exist at both the synaptic and
behavioral levels within which the greatest periods of phenotypic
change occur and where lack of sensory experience has the most
significant effects. These timeframes are commonly referred to
as “critical” periods when investigating mechanisms of synaptic
and molecular changes. They are also referred to as “sensitive”
periods for many behaviors, although the distinction of usage
and the exact ending of these periods is not always clear-cut
(Johnson, 2005; Michel and Tyler, 2005). Here, we use the term
“critical period” to refer to both synaptic and behavioral pheno-
types that occur during documented neurotypical developmental
stages.
At the level of the synapse, development and formation of
functional connections during neurotypical maturation follows
an established sequence: initial axonal and dendritic outgrowth,
excess formation of immature long thin filopodia-like spines
and subsequent pruning of synaptic contacts accompanied by
an activity-induced maturation of remaining synapses (Katz and
Shatz, 1996; Ethell and Pasquale, 2005; West and Greenberg,
2011). Whilst synapse remodelling is a lifelong process (Holtmaat
et al., 2005; Grillo et al., 2013), the peak of synapse development
and synaptic connectivity is predominantly established during
early postnatal periods in vertebrates (Pan and Gan, 2008).
For primary sensory cortices, the network is shaped by sensory
input during the critical period coinciding with a high level of
synaptic and neuronal remodelling. Thus, during neurotypical
development, critical periods for the greatest changes in synaptic
circuits in the brain and behavior are defined when the system
is most susceptible to change. As such, plasticity of specific
phenotypes is heightened relative to earlier or later developmental
stages.
MOLECULAR PATHWAYS INVOLVED IN MONOGENIC NDD
CONVERGE ON SYNAPSE FUNCTION
Aberrant spine morphology is characteristic for individuals with
NDDs as post-mortem studies report an abundance of imma-
ture, long thin spines and in some cases, altered spine density
(Kaufmann and Moser, 2000; Ramakers, 2002; He and Portera-
Cailliau, 2013; Maynard and Stein, 2012). Morphological aber-
rations also occur in non-syndromic ID where dendritic spine
impairments correlated with age and severity of developmental
disability (Purpura, 1974; Ramakers, 2002). Thus, a body of
evidence from human post-mortem studies indicates a strong
correlation between altered structural development of synapses
and NDDs.
Initial stages of synapse formation and neuronal connectivity
require modulation of the cytoskeletal F-actin via the Ras
homologue subfamily of Rho GTPases. Many genes underlying
monogenic NDDs interact directly with Rho signaling protein
pathways. (Figure 1; Ramakers, 2002; Ethell and Pasquale, 2005).
This family of small-GTPases includes ras homolog gene family,
member A (RhoA), ras-related C3 botulinum toxin substrate
(Rac1) and cell division cycle 42 (Cdc42), which dynamically
regulate protrusion and retraction of spines via cytoskeletal
actin remodelling (Tashiro et al., 2000; Ethell and Pasquale,
2005). Small guanosine-5′-triphosphate hydrolyzing enzymes
(GTPases) typically cycle between active GTP-bound and inactive
guanosine diphosphate- (GDP) bound states. These transitions
are dynamically regulated by GTPase activating proteins (GAPs),
guanine nucleotide exchange factors (GEFs), and by GDP disso-
ciation inhibitors (GDI) inhibiting the conversion to the active
GTP-bound state (Sasaki and Takai, 1998). In syndromic OPHN1
ID, changes in spine morphology are caused by the absence of
OPHN1, a RhoA-GAP (Govek et al., 2004). The ID Williams
syndrome is linked to the LIM domain kinase 1 (LIMK1) gene,
whose product mediates changes in actin and spine morphology
via Cdc42 and Rac1 pathways (Edwards et al., 1999). Additionally,
LIMK1 interacts with P21-activated kinases (PAKs) which also
harbor mutations in many nonsyndromic human ID cases (Allen
and Walsh, 1999). Rho family members are activated by extra-
cellular stimuli via growth factors and neurotransmitter release.
Brain-derived neurotrophic factor (BDNF), involved in synaptic
maturation, activates Rac/RhoA-GEF proteins via TrkB tyrosine
kinase (TrkB) receptors and induces spine head growth (Hale
et al., 2011). During synaptic activation, glutamatergic trans-
mission activates 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)
propanoic acid receptor (AMPA) and N-Methyl-D-aspartic acid
or N-Methyl-D-aspartate (NMDA) receptors and subsequently
activates Rho proteins (Sin et al., 2002). Therefore, activity of the
Rho proteins is sensitive to synaptic transmission and can regulate
activity-induced maturation of the synapse. Synaptic maturation
requires structurally modifying the synapse via cell-adhesion
proteins including CNTNAP2, neuroligins 3 and 4, neurexin1,
δ-catenin and associated Shank and Homer proteins which are
frequently implicated in ASD (Tu et al., 1999; Sala et al., 2001;
Jamain et al., 2003; Sudhof, 2008; Matter et al., 2009; Anderson
et al., 2012). These proteins ensure proper synapse formation
by bridging the pre- and postsynaptic sites, acting as a scaffold
and stabilizing the cytoskeleton of the synapse (Kosik et al.,
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FIGURE 1 | Several NDD-associated genes function at the synapse.
Monogenic NDD genes (red) expressed in the synapse, illustrated here
postsynaptically, mediate spine morphology changes via small
GTPase-mediated signaling pathways and F-actin in response to synaptic
activation via BDNF and glutamatergic excitation. Abbreviations: 4EBP1,
eukaryotic translation initiation factor 4E-binding protein 1; AMPA,
2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid receptor; Cdc42,
cell division cycle 42; CYFIP, cytoplasmic binding partner of fragile X
protein; eIF4E, eukaryotic translation initiation factor 4E; FMRP, fragile X
mental retardation protein; LimK1, LIM domain kinase 1; mGluR5
metabotropic glutamate receptor subunit 5; mTOR1, mammalian target of
rapamycin 1; NMDA, N-Methyl-D-aspartic acid or N-Methyl-D-aspartate
Receptor; OPHN1, oligophrenin-1; PAK, P21-activated kinase; Rac1,
ras-related C3 botulinum toxin substrate; Rheb, Ras homolog enriched in
brain; RhoA, ras homolog gene family, member A; TrkB, TrkB tyrosine
kinase; Tsc 1, tuberous sclerosis protein 1; Tsc 2, tuberous sclerosis
protein 2.
2005; Takeichi and Abe, 2005; Penagarikano and Geschwind,
2012). Since the Rho signaling pathways and synapse-spanning
complexes are enriched with NDD-related proteins, they provide
a direct link between NDDs and aberrant synapse development.
In addition to direct modulation of the cytoskeleton,
many NDD-related proteins are regulators of gene transcrip-
tion, mRNA translation and ultimately protein synthesis (Nan
et al., 1997; Bagni and Greenough, 2005; Kelleher and Bear,
2008; Guy et al., 2011). NMDA-dependent, metabotropic gluta-
mate receptor (mGluR)-dependent and BDNF-induced synap-
tic plasticity mechanisms depend on protein synthesis via the
Ras-mitogen-activated protein kinase (Ras-MAPK) pathway and
directly or indirectly modulate TSC 1/2 complex activity (Sweatt,
2004; Banko et al., 2006; Gong and Tang, 2006; Kelleher and
Bear, 2008). Misregulation of mRNA translation, particularly for
synaptic proteins, is proposed to underlie many “synaptopathies”
with impairments or loss of fragile X mental retardation protein
(FMRP), TSC 1/2, ubiquitin-protein ligase E3A (UBE3A) and
eukaryotic translation initiation factor 4E (eiF4E) all causing
altered protein synthesis (Auerbach et al., 2011; Zoghbi and Bear,
2012; Santini et al., 2013). Furthermore, altered transcriptional
regulation via methyl CpG binding protein 2 (MECP2) is also
linked to prominent impairments in Rett syndrome (Guy et al.,
2011). Thus, the effects of many NDD-linked genes occur at the
level of spine morphology, synapse function and regulation of
local protein synthesis in the developing and adult mammalian
brain.
TEMPORAL SYNAPTIC PHENOTYPES AND CRITICAL
PERIODS IN NDD MOUSE MODELS
Across different NDD mouse models, studies consistently report
an abundance of thin immature filopodia-like spines and small
spine heads (Meng et al., 2002; Galvez and Greenough, 2005;
Cruz-Martin et al., 2010; Maynard and Stein, 2012; Powell et al.,
2012) and/or an altered spine density (Dolen et al., 2007; Meikle
et al., 2007; Yashiro et al., 2009; Sato and Stryker, 2010; Powell
et al., 2012). In many models, alterations in synaptic phenotypes
are often reported at one developmental stage, often correspond-
ing to adult symptomatic stages or a period of 2–3 weeks postnatal
age during which extensive refinement and plasticity of synapses
occurs in rodent brain. However, data derived from longitudinal
studies support the notion of developmentally regulated and
transient phenotypes in NDD models.
In typically developing somatosensory cortex, spine morphol-
ogy changes greatly between postnatal weeks 1–4, shifting from
a high proportion of transient, thin “immature” spines to more
mature, long-lasting stubby spines (Ethell and Pasquale, 2005).
However, in Fmr1-KO mice, this transition is delayed at 2 weeks
of age (Cruz-Martin et al., 2010) but both spine morphology
and dynamic turnover are normalized around one month of age
(Nimchinsky et al., 2001; Cruz-Martin et al., 2010). Intriguingly,
the immature spine phenotype reappears in the adult Fmr1-KO
mice (Galvez and Greenough, 2005) similar to the pattern of
transient changes in spine morphology observed in the down
syndrome cell adhesionmolecule knockout (DSCAM-KO)mouse
model for Down Syndrome (Maynard and Stein, 2012). Crit-
ical periods in the somatosensory cortex occur in a sequen-
tial pattern, from subcortical to later cortico-cortical changes
(Fox, 2002; Feldmeyer et al., 2013). Transient phenotypes are
also observed in thalamocortical pathways: in Fmr1-KO mice,
enhanced NMDA/AMPA synaptic ratios and altered plasticity
occur during the first but not by the end of the second postnatal
week, indicating developmental delays within the neurotypical
critical period for this pathway (Harlow et al., 2010). In contrast,
premature maturation of thalamocortical NMDA/AMPA ratios
and plasticity occurs in heterozygous mice for SynGap1, a Ras
GTPase-activating protein implicated in ID and ASD but this
also normalizes at the end of the first postnatal week (Clement
et al., 2013). During the second postnatal week, after the cessa-
tion of thalamocortical plasticity, decreased connectivity strength
and diffuse axonal branching occurs in cortical circuits between
layers 4 and 2/3 of Fmr1-KO mice. Again, these deviations from
neurotypical development are restricted and normalize one week
later (Bureau et al., 2008). Thus, in somatosensory cortex, many
transient changes occur during established critical periods for
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particular synaptic pathways. Such transient NDD phenotypes
are not limited to sensory cortex but also occur in other brain
regions including medial prefrontal cortex (Testa-Silva et al.,
2012), amygdala (Vislay et al., 2013) and olfactory epithelium
(Palmer et al., 2008).
In addition to aberrations in critical periods for synapse and
circuit formation, dysregulated synaptic phenotypes occur during
critical periods for adaptation to sensory deprivation. Ocular
dominance and experience-dependent plasticity mechanisms in
response to monocular deprivation (MD) are documented well
for themouse visual cortex and occur during a restricted postnatal
period. In Fmr1-KO mice, a short MD period induced a signif-
icantly smaller reduction in response in the deprived cortex and
an enhanced potentiation of input from the open eye compared
to wildtype (WT) mice (Dolen et al., 2007). A lack of plasticity in
the deprived cortex after MD was also observed in m-UBE3A-KO
mice, a model for Angelman syndrome where the maternal gene
copy is lacking (Yashiro et al., 2009; Sato and Stryker, 2010). This
effect was not due to a developmental shift in the critical period
for m-UBE3A-KO mice since no change in response to MD was
observed if the deprivation occurred before, during or after the
neurotypical critical period (Sato and Stryker, 2010).
The closure of the critical period for ocular dominance can be
manipulated by changes in inhibition or by sensory deprivation
through rearing mice in the dark (Hensch, 2005). In heterozygous
MECP2-KO female mice, ocular dominance plasticity in response
to MD could be induced far beyond the neurotypical critical
period into young adulthood, suggestive of a lack of maturation
and normal closure of this plasticity mechanism (Tropea et al.,
2009). Early synaptic development of the visual system in MECP2
null mice appears normal up to P21 but is followed by later
impairments of retinogeniculate synapses (Noutel et al., 2011),
increased cortical inhibition and ultimately, impaired visual acu-
ity (Durand et al., 2012). These later developmentally regulated
changes in the MECP2 mouse model reflect the protein’s pro-
posed role in synaptic maintenance during adult stages (Guy et al.,
2007; Robinson et al., 2012) similar to late postnatal onset of
impairments in the Cri-du-Chat mouse model (Matter et al.,
2009) but in contrast to other NDD models displaying earlier
synaptic phenotypic impairments.
What are the consequences of a dysregulated synaptic pheno-
type or altered critical period in the developing brain? During
retinotopic map development, disruption of synaptic activity
during an early critical period alters later neuronal connectivity
within the visual system. Desynchronization of early retinal waves
of neuronal activity in mouse pups lacking the β2- nicotinic
acetylcholine receptor subunit is a transient phenotype restricted
to the first but not second postnatal week of development. This
altered activity results in an impaired finescale refinement of reti-
nal axons in the brainstem (Grubb et al., 2003; Mclaughlin et al.,
2003), altered geniculocortical projections (Cang et al., 2005) and
a decrease in visual acuity at the cortical level (Rossi et al., 2001).
Therefore, disruption or loss of an early critical period can influ-
ence both functional and structural connectivity not only in the
affected region but in other areas of the sensory processing system
and result in altered sensory perception. Applying this principle
to NDDs, early or transient alterations in synaptic phenotypes
during known critical periods could account for later aberrations
in synaptic function, morphology and potentially even behavioral
impairments of sensory information processing that characterize
many of these disorders.
NEURAL CONNECTIVITY AND EXCITATION-INHIBITION
BALANCE IN NDDs
Abnormalities in connectivity of excitatory and inhibitory neu-
rons in NDDs are documented at many different levels from
whole-brain functional imaging studies to electron microscopic
changes in synaptic morphology (Kaufmann and Moser, 2000;
Belmonte et al., 2004; Belmonte and Bourgeron, 2006; Dinstein
et al., 2011). Dysregulation of excitatory/inhibitory (E/I) balance
is proposed to impair neural processing and underlie cognitive
deficits in many ID and autistic syndromes (Rubenstein and
Merzenich, 2003). E/I is aberrant in many NDD mouse models:
some have increased excitability [FXS: (Hays et al., 2011; Testa-
Silva et al., 2012; Goncalves et al., 2013), TSC: (Bateup et al.,
2013)], ASD models (Peca et al., 2011; Penagarikano et al.,
2011; Clement et al., 2012) whilst others show increased inhibi-
tion [Downs: (Fernandez et al., 2007; Chakrabarti et al., 2010;
Kleschevnikov et al., 2012) Rett: (Dani et al., 2005; Noutel et al.,
2011; Durand et al., 2012), but see Calfa et al. (2011) and Kron
et al. (2012)]. Thus dysregulation of either excitation or inhibition
can disrupt the correct E/I balance in NDDs.
The interaction between E/I balance and development of
synaptic networks during critical periods is likely a complex and
finely tuned set of processes. In visual cortex, maturation of inhi-
bition triggers critical period onset accompanied by regulation
of excitatory synapse strength via activity-dependent mechanisms
(Hensch, 2005). Thus both timing and synaptic maturation dur-
ing critical periods depend upon a delicate interplay of both
excitatory and inhibitory transmission and as such, are vulnerable
to NDDs affecting E/I balance directly. An indirect effect of NDDs
upon E/I balance could also arise if perturbations occur to delay or
disrupt a critical period, thereby altering the correct development
of synaptic connectivity. Given the sequential nature of synapse
development from thalamocortical to sensory cortical regions, an
early aberration affecting E/I balance during one critical period
could give rise to impairments in a subsequent critical period of a
cortical network. Thismay occur either directly via the same E/I—
critical period mechanism or as a consequence of, for example,
impairments in the outgrowth of axonal projections from one
synaptic network to the next.
A prevailing hypothesis in NDD research proposes a weak-
ening of long-range projections in addition to a strengthening
of local-range connectivity in the brain (Belmonte et al., 2004;
Just et al., 2004). Local hyperconnectivity of excitatory networks
in neocortex is observed in mouse models for FXS (Testa-Silva
et al., 2012; Goncalves et al., 2013) and ASD (Rinaldi et al., 2008;
Qiu et al., 2011) but Rett syndrome models show local hypocon-
nectivity (Dani et al., 2005). However, significantly less is known
about long-range connectivity at the synaptic level in NDD
mouse models or whether developmental trajectories are misreg-
ulated. It is likely that impairments in long-range projections in
NDDs are not global but rather synapse-specific: alterations in
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long-range projections occur at cortical but not thalamic inputs
to the lateral amygdala in a mouse model for Rett syndrome
(Gambino et al., 2010) and in the ID associated gene il1rapl1
mouse model, thalamo-amygdala projections differ only on to
principal cells but not interneurons (Houbaert et al., 2013).
Furthermore, the period for normal synapse elimination andmat-
uration of long-range projections to lateral amygdala occurred
after 3 months of age, indicating that refinement of this synap-
tic pathway occurs relatively late in postnatal development and
could potentially be disrupted by many other early critical period
impairments (Gambino et al., 2010). Given the tightly regulated
growth of the brain and sequential patterns of development from
one synaptic network to another (Ben-Ari and Spitzer, 2010),
we propose that long-range connectivity may be particularly
vulnerable in NDDs, especially where the NDD-linked genes are
strongly expressed at prenatal or early postnatal time-windows
in brain development (Meredith et al., 2012). In a recent study,
preliminary data reported infants at high risk for ASD had higher
long-range functional connectivity than those at low ASD risk
at 3 months age but lower connectivity at 12 months (Keehn
et al., 2013). Thus longitudinal studies of interregional projections
in the brain could reveal whether the key NDD hypothesis of
weakened long-range connectivity is specific to the mature brain
or applies also to early developmental stages, and how early brain
connectivity relates to the onset of NDD symptoms.
MECHANISMS UNDERLYING CRITICAL PERIODS AND NDDs
The existence of sensitive time-windows for the manifestation of
symptoms in animal models of neurological and neuropsychiatric
disorders has recently been proposed (Leblanc and Fagiolini,
2011; Marco et al., 2011; Martin and Huntsman, 2012; Meredith
et al., 2012). Here, we hypothesize that the concept of critical
or sensitive periods can be applied to underlying mechanisms of
NDDs in two ways.
First, the underlying pathology of NDDs could arise
through aberrant interactions during existing critical period
mechanisms that are in place during neurotypical development
(Figures 2A, C). For example, both ocular dominance plasticity
and mapping of frequency representation during their respective
critical periods are impaired in the Fmr1 KO mouse but can
be restored by reduction of metabotropic glutamate receptor
subunit 5 (mGluR5) expression or pharmacological blockade
(Dolen et al., 2007; Kim et al., 2013). The Fmr1 gene product,
FMRP, is activated following mGluR5 stimulation and regulates
synaptic mRNA translation and (Weiler et al., 1997) mGluR5
activation is necessary for certain types of synaptic plasticity
(Huber et al., 2000; Raymond et al., 2000). Attenuation of
mGluR5 signaling dysregulates both experience-dependent
NMDA receptor expression and synaptic plasticity in young and
adult visual cortex, respectively (Tsanov and Manahan-Vaughan,
2009). Therefore, the absence of FMRP in FXS affects the level of
synaptic plasticity via mGluR5-mediated signaling dysregulation,
which in turn affects the level of response during the critical
period for ocular dominance.
The timing aspects of known critical periods in NDDs could
also be affected via GABAergic inhibition. GABAergic inhibition
is significantly altered inmany NDDs (Rubenstein andMerzenich,
2003; Chattopadhyaya and Cristo, 2012). Intact GABAergic inhi-
bition is necessary for the critical period for ocular dominance
to occur: KO mice lacking the 65 kD isoform of the GABA
production protein glutamate decarboxylase (GAD65) have
impaired GABA function and do not show a normal critical
period for ocular dominance (Hensch et al., 1998). The crit-
ical period can be induced experimentally by pharmacologi-
cally increasing GABAA receptor function (Hensch et al., 1998;
Fagiolini et al., 2004). This opening of the critical period can be
achieved independently of the age of the mice, indicating that
adequate GABAergic signaling is necessary for the critical period
to occur, while other mechanisms that act during the critical
period are already in place. Thus, an alteration in GABAergic
inhibition during brain development in NDDs can thereby lead
indirectly to perturbations in the timing of critical periods.
The second concept to link NDDs and critical periods during
development is that the expression profile of the gene underlying
an NDD may in itself constitute a critical period during which
the effects of the NDD are manifest (Figure 2B). This deviates
slightly from the general definition of a critical period, as it
does not necessarily pertain to external stimuli affecting network
development. In this model, upregulation of a gene at a particular
time is necessary for the network to develop normally. It is
therefore a critical period in the sense that expression of the
gene is necessary during a particular time-frame. This has been
shown in a Drosophila model for FXS, where reintroduction of
the Drosophila homologue of FMRP (dFMRP) in the knock-out
model rescues certain aspects of synaptic morphology only during
a 2 day time-window, but not during earlier development or later
in the adult (Gatto and Broadie, 2009).
TEMPORALLY DYSREGULATED GENE EXPRESSION
UNDERLYING NEURODEVELOPMENTAL BRAIN DISORDERS
Gene expression is a dynamic process throughout life and is
tightly regulated on both spatial and temporal dimensions. The
transcriptome, the collective expression of multiple genes, differs
significantly in a tissue-specific and brain region-specific pattern
across both cortical and subcortical structures in mammals (Allen
Brain Atlas,1 Hawrylycz et al., 2012). Transcriptomic profiles
reveal distinct layer-specific and non-layer-specific expression
patterns for many thousands of genes in the sensory neocortex
of adult mouse (Belgard et al., 2011). Similarly, robust genetic
signatures for individual cortical layers and also specific brain
regions are found in both human and non-human primates, with
greater similarity in lamination between primate species than to
rodents (Belgard et al., 2011; Bernard et al., 2012).
Given the protracted development of human brain over
many years, it is not surprising that the spatial transcriptome
varies considerably over time: in humans, more than 90% of
detected genes in the brain are differentially regulated in a
spatio-temporal manner from embryonic through to geriatric
periods (Kang et al., 2011). The greatest changes in regional
gene expression occur during prenatal and early postnatal peri-
ods (Colantuoni et al., 2011; Kang et al., 2011). In the mouse
brain, cohorts of genes are differentially expressed in the sub-
1www.brain-map.org
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FIGURE 2 | Two ways in which dysfunction of NDD genes can
dysregulate critical periods. A critical period is shown here as the
timeframe between “1” and “2”. (A) In this scenario, the critical period is
caused by external factors (blue bar) not related to the NDD gene and
expression of the NDD gene in wild-type is not necessarily atlered before,
during or after the critical period (red area). However, the NDD gene plays a
role downstream of these external factors and is necessary for phenotypic
change to take place, thereby indirectly regulating not the occurrence but the
outcome of the critical period. Hence, dysfunction of the gene leads to an
impaired critical period. (B) Increased NDD gene expression (red area)
directly regulates the critical period and causes it to occur, independent of
external factors. Therefore, dysfunction of the NDD gene causes the critical
period to be absent completely. (C) In both scenarios, the NDD gene is
necessary for the phenotypic change that takes place during the critical
period (“WT” vs “KO”), represented here by maturation of spine
morphology.
plate at specific developmental stages from late embryonic
through to early and late postnatal periods (Hoerder-Suabedissen
et al., 2013). Thus, the transcriptome is tightly regulated in
the neurotypical mammalian brain and reveals both restricted
expression windows and developmentally changing gradients of
gene expression.
The developmental regulation of spatial patterns of individ-
ual gene expression in the neurotypical brain includes many
known NDD candidate genes for monogenic syndromes (Allen
Brain Developing Human and Mouse Brain Atlas,2). Of interest,
many genes linked to ASD show dynamic changes in expression
in subplate layers of the mouse cortex, suggesting disruption
of early developmentally regulated NDD candidates (Hoerder-
Suabedissen et al., 2013). However, the direct functional effects of
these gene changes are not yet known. Prominent genes underly-
ing ID and ASD, including Fmr1, neurofibromin (NF1) and TSC
1/ 2 show strong developmental mRNA upregulation particularly
from late embryonic stages onwards (Figure 3). For Fmr1, this
upregulation is transient, peaking between postnatal days (P)
4 and 14 in telencephalic and thalamic defined regions before
decreasing by P28 (Figure 3). Given that transient phenotypes in
thalamocortical and cortico-cortical synaptic pathways occur in
the Fmr1-KO mouse model, it is plausible that these temporal
impairments only arise during periods of peak expression for
2https://molnar.dpag.ox.ac.uk/subplate
the Fmr1 gene. That is to say, irregularities in an NDD only
result in a phenotype at the time when the NDD gene peak
expression would usually occur in neurotypical development. No
synaptic NDD phenotype is observed if the gene is not promi-
nently being expressed in that brain region and as such, there
is no noticeable impairment in the KO mouse model at that
stage.
Exome sequencing of many hundreds of families with individ-
uals affected by ID and ASD reveal a high genetic heterogeneity
and many de novo mutations (Neale et al., 2012; O’Roak et al.,
2012; Sanders et al., 2012). Whilst changes in individual gene
expression can be tracked throughout development of the brain,
much insight can be gained from groupings of genes based on
cell-type expression, synaptic location, similar cellular functions,
or spatio-temporal expression patterns (Ruano et al., 2010; Kang
et al., 2011; Hawrylycz et al., 2012; Lips et al., 2012). Clustering
genes into such modules proves extremely useful for genetically
heterogeneous disorders, such as ASD and ID, where individual
genes explain, at best, a few percent of cases (Manolio et al.,
2009; Ruano et al., 2010; Voineagu et al., 2011). In autistic
brain samples, grouping many genes in network modules based
on differential expression patterns revealed a downregulation in
specific networks related to synaptic function. Additionally, gene
networks for astrocytic/microglia function and immune func-
tion were enriched relative to neurotypical age-matched brain
(Voineagu et al., 2011).
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FIGURE 3 | Temporal regulation of genes for syndromic NDDs during pre-
and postnatal brain development. Developmental profiles of RNA levels for
specific monogenic ID and ASD genes in pre- and postnatal development, in
telencephalon and thalamic (Area P2) regions. Data extracted from Allen
Developing Mouse Brain Atlas Website: © 2012 Allen Institute for Brain
Science. Allen Developing Mouse Brain Atlas [Internet].3 Abbreviations:
Fmr1, Fragile X mental retardation 1; LimK1, LIM domain kinase 1; NF1,
neurofibromin; SHANK3, SH3 and multiple ankyrin repeat domains 3;
TSC1/TSC2, tuberous sclerosis protein 1/2; UBE3A, ubiquitin-protein ligase
E3A.
Many NDD gene products regulate expression of many other
target genes and orchestrate a cascade of signaling proteins. In
FXS, FMRP regulates over 800 mRNA targets (Brown et al.,
2001; Vanderklish and Edelman, 2005; Darnell et al., 2011) and
alters expression of many different synaptic proteins (Adusei
et al., 2010; Klemmer et al., 2011). These FMRP targets are
common to regulation throughout the nervous system (Ascano
et al., 2012), occur both pre- and postsynaptically and can be
grouped according to broad biological functions (Darnell et al.,
2011). Thus, for complex disorders, a gene clustering approach on
differential expression patterns may likely yield many new targets
and therefore insights into the mechanistic basis of these NDD
syndromes.
To-date, much emphasis is placed upon the individual signal-
ing pathways dysregulated in specificmonogenicNDDs. However,
it is apparent that there may be key “hubs” that act as common
points of dysregulation within the many signaling pathways in ID
and ASD (Bill and Geschwind, 2009; Sakai et al., 2011; Voineagu
et al., 2011; Zoghbi and Bear, 2012). Shared pathophysiological
signaling pathways are of importance for rescue strategies of
synaptic function, protein synthesis and behavioral impairments
in mouse models of FXS, TSC and neuroligin-3 (Auerbach et al.,
2011; Baudouin et al., 2012). The heterogeneity of NDDs of ID
and ASDs proves a major source of difficulty for both researchers
and the pharmaceutical industry to propose unifying mechanisms
that underlie these disorders and importantly, to find viable
therapeutic targets. Clinical testing of multiple targets specific for
each syndrome is costly both in time and money. Identification
of “hub” NDD genes or their key targets with high expression
relatively early in development could provide a new therapeutic
angle to intervene in particular NDDs. This approach is by no
means straightforward and given the sequential development of
critical periods in different brain regions, would be difficult to
restrict therapeutic actions to specific synaptic pathways. How-
ever, the current testing of mGluR5 inverse agonists in phase II
and III clinical trials for cognitive and behavioral phenotypes in
FXS is being extended to younger children (Levenga et al., 20104).
Whether developmental age in clinical trials affects outcome is
not known, but in the Fmr1-KO mouse model, a greater effect of
mGluR5 blockadewas observed upon rescue of spinemorphology
in young compared to old neurons (Su et al., 2011). Furthermore,
these findings will have implications for other NDDs with poten-
tial for early developmental dysregulation of mGluR5 signaling
(Zoghbi and Bear, 2012).
3http://developingmouse.brain-map.org
4www.fraxa.org
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TESTABLE HYPOTHESES FOR VALIDATION IN NDDs
On these bases outlined, we propose three testable hypotheses
(Box 1) to guide further investigation into neurobiological mech-
anisms for pathology of NDDs:
During development of sensory systems in the neurotypical
brain, critical periods occur in a sequential pattern from brain-
stem, to thalamus to cortical regions as synapses form, refine and
mature. Given that critical periods at thalamocortical and cortico-
cortical synaptic pathways are affected in NDDs, we propose
that dysregulation of synaptic pathways occurs at the subcortical
level in NDDs at earlier stages than are currently known, dur-
ing “presymptomatic” stages (Hypothesis 1). For human NDD
syndromes, this could point towards prenatal and early neonatal
changes in brain formation and function at stages not currently
tested in the clinic. The implications of abnormalities in brain
activity at such early developmental stages would be significant
initially for detection and screening for NDDs in the fetus or new-
born baby and raise possibilities for therapeutic interventions,
technological challenges notwithstanding. It may also challenge
the notion at which point a child is considered to be presymp-
tomatic, if changes in brain activity are found at increasingly
younger developmental stages.
Many NDD genes exhibit prominent expression in subcortical
brain regions as well as in more commonly studied cortical
circuitry (Allen Brain Atlas5). Building on the observations of
sequential disrupted critical periods in NDDs, we postulate that
in sensory circuits of a NDD, dysregulation of a critical period
in subcortical regions such as the brainstem precedes and conse-
quentially disrupts subsequent critical periods in thalamus and
then cortex (Hypothesis 2). Thus, dysregulation and potential
developmental delay for one known critical period would have a
knock-on effect for synaptic circuits regulated at later timepoints
at downstream synaptic pathways. Little is known regarding sub-
cortical brain regions in NDDmousemodels. However, alteration
of GABAergic transmission and reduction of GABA-A receptor
subunits is reported at postnatal day 7 in ventrolateral brainstem
of MECP2 KO mice (Medrihan et al., 2008). Current use of
constitutive knock-out mouse models for genetic NDDs are valid
experimental tools to detect such early changes: however, condi-
tional knockout models where gene expression can be temporally
controlled in specific cell types would better enable proof of a
causal relation between a disrupted critical period in subcortical
regions directly leading to later cortical impairments. Combining
knowledge of the critical periods for specific mouse brain regions
in neurotypical normal development with the temporal expres-
sion profile of genes implicated in NDDs can guide the spatial and
temporal parameters for designing these experiments.
Observations in mouse models of genetic NDD syndromes,
demonstrate that alterations in synaptic networks occur during
early brain development. Taking the Fmr1-KO mouse model, for
example, reported thalamocortical and cortico-cortical synaptic
impairments correlate with FMRP expression that occurs in the
normally developing brain (Harlow et al., 2010; Meredith et al.,
2012). Although it may be purely coincidental that synaptic
impairments in an NDD model co-occur with the normal time
5http://www.brain-map.org/
period for peak expression of that NDD gene, we believe these
are directly linked and that the most prominent phenotypic
impairments first occur during the period when the gene would
be normally activated and most strongly expressed in the brain.
Therefore, we propose that no differences in synaptic networks
or critical periods in NDDs occur prior to the neurotypical pre-
or postnatal expression of the NDD gene in that brain region
(Hypothesis 3). Thus, a gene with limited postnatal expression
in the brain would not give rise to aberrant prenatal synaptic
phenotypes since the gene is not normally activated in cells prior
to birth. One upshot of this idea is that discovery of prenatal
expression patterns of a gene implicated in NDDs may not only
lead to detection of prenatal synaptic phenotypes but highlight
additional previously unknown functions of a gene during early
developmental stages of the nervous system.
COMPENSATORYMECHANISMS IN SYNAPTIC NETWORKS
AND BEHAVIORAL PROCESSING
Alterations in activity levels during early neuronal network
development lead to remodelling and compensatory changes in
synaptic strength, a phenomenon known as homeostatic plasticity
(Turrigiano and Nelson, 2004). This plasticity mechanism enables
a network to regulate its synaptic activity in response to the
dynamics of the local environment changed by both intrinsic
factors and external stimuli, such as sensory input during early
postnatal periods (Marder and Goaillard, 2006). Lack or loss-
of-function mutations in MeCP2 disrupts homeostatic network
plasticity in both developing cortex (Blackman et al., 2012) and
hippocampal cultures (Qiu et al., 2012). Further, lack of FMRP
disrupts one specific type of homeostatic plasticity dependent
upon retinoic acid and protein synthesis in developing hippocam-
pal networks (Soden and Chen, 2010). Thus, later symptomatic
changes in brain networks in some NDDs could arise indirectly
from impairments in network homeostasis rather than direct
synaptic effects of the NDD protein itself.
The transience of synaptic impairments observed during
sensitive time-windows (Meredith et al., 2012) could also be
influenced by network compensation mechanisms acting to nor-
malize synaptic phenotypes through homeostatic plasticity at that
particular developmental stage. For many NDD target proteins,
while they may play a key “hub” role in regulating transcription
and translation processes in the cell or signaling at the synapse
(Bill and Geschwind, 2009; Zoghbi and Bear, 2012), they are
not the sole regulator and residual function is likely to be medi-
ated by additional candidates within a synaptic network. Indeed,
the initial delays but not absences of key synaptic phenotypes
observed in many NDDs (referred against the already known
“developmental checkpoints”, Ben-Ari and Spitzer, 2010) could be
due to the extra time necessary for compensatory mechanisms to
regulate and support the network, taking over residual functions
not provided by the (missing) NDD gene.
Compensatory mechanisms may also operate during devel-
opmental stages of NDDs at the level of systems processing and
behavior (Johnson, 2012). In an imaging study of young chil-
dren with diagnosed ASD, fMRI revealed significant differences
in brain activation patterns compared with neurotypical age-
matched children during a simple motion perception task (Kaiser
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et al., 2010). However, more interestingly, the unaffected siblings
of ASD participants with shared genes and an increased risk for
later developing ASD showed significantly different activation
patterns to both their siblings and neurotypical controls during
the task. Increased activation occurred in ventromedial prefrontal
cortex and right posterior superior temporal sulcus, two regions
associated with motion processing and general executive func-
tion skills (Bechara et al., 2000). These neuro-“endophenotypes”,
characteristics reflecting susceptibility for a genetic disorder not
manifesting as a clinically defined phenotype, could reflect com-
pensatory processing in the brains of those individuals with
higher genetic risks for NDDs but not sufficient alterations to
warrant a diagnosis.
In conclusion, establishing the mechanisms that underlie early
time windows for aberrations in synaptic circuits and impaired
behavioral development in NDDs has the potential to reveal new
approaches for pharmacotherapeutic correction of brain activity
during early development or even new neurobiological gene tar-
gets (Levenga et al., 2010; Meredith et al., 2012). Furthermore, we
believe this approach outlined in a set of testable hypotheses may
reveal dysregulation of brain activity and neuronal circuit for-
mation at significantly earlier presymptomatic stages in nervous
system development than previously thought in both syndromic
and nonsyndromic neurodevelopmental brain disorders.
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